Risk of Prion Disease Transmission through Bovine-Derived Bone Substitutes: A Systematic Review

Clinical Implant Dentistry and Related Research

Volumn 15, Issue 5, 2013, Pages 645-653

  Kim, Yeoungsug ^a   Nowzari, Hessam ^a   Rich, Sandra K ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Anorganic bovine bone substitutes; BSE diagnostic test; BSE prion inactivation; BSE prion infectivity; Protein; PrP(27 30); PrPSc

Indexed keywords

BONE PROSTHESIS;

ANIMAL; BONE PROSTHESIS; BOVINE; BOVINE SPONGIFORM ENCEPHALOPATHY; RISK FACTOR; TRANSMISSION;

ANIMALS; BONE SUBSTITUTES; CATTLE; ENCEPHALOPATHY, BOVINE SPONGIFORM; RISK FACTORS;

EID: 84885864783     PISSN: 15230899     EISSN: 17088208     Source Type: Journal    
DOI: 10.1111/j.1708-8208.2011.00407.x     Document Type: Article

References (54)

1. Will RG, Ironside JW, Zeidler M, etal. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 1996; 347:921-925.
2. Collinge J, Sidle KC, Meads J, Ironside J, Hill AF. Molecular analysis of prion strain variation and the aetiology of "new variant" CJD. Nature 1996; 383:685-690.
3. Bruce M, Chree A, McConnell I, Foster J, Pearson G, Fraser H. Transmission of bovine spongiform encephalopathy and scrapie to mice: strain variation and the species barrier. Philos Trans R Soc Lond B Biol Sci 1994; 343:405-411. (Review).
4. Sogal A, Tofe AJ. Risk assessment of bovine spongiform encephalopathy transmission through bone graft material derived from bovine bone used for dental applications. J Periodontol 1999; 70:1053-1063.
5. Donnelly CA, Ferguson NM, Ghani AC, Anderson RM. Implications of BSE infection screening data for the scale of the British BSE epidemic and current European infection levels. Proc Biol Sci 2002; 269:2179-2190.
6. Supervie V, Costagliola D. The unrecognized French BSE epidemic. Vet Res 2004; 35:349-362.
7. Ducrot C, Arnold M, de Koeijer A, Heim D, Calavas D. Review on the epidemiology and dynamics of BSE epidemics. Vet Res 2008; 39:15. Epub January 11, 2008. (Review).
8. Stack MJ, Focosi-Snyman R, Cawthraw S, Davis L, Chaplin MJ, Burke PJ. Third atypical BSE case in Great Britain with an H-type molecular profile. Vet Rec 2009; 165:605-606.
9. Kadohira M, Stevenson MA, Kanayama T, Morris RS. Epidemiology of bovine spongiform encephalopathy in cattle in Hokkaido, Japan, between September 2001 and December 2006. Vet Rec 2008; 163:709-713.
10. http://web.archive.org/web/20130922163414/http://www.fda.gov/OHRMS/DOCKETS/98fr/08-1180.pdf (accessed February 6, 2011).
11. Brink S, Shute N. Is it safe? New beef rules aim to stop mad cow disease. But they may not be enough - and there's too much we don't know. US News World Rep. 2004; 136:16-21.
12. Takada N, Horiuchi M, Sata T, Sawada Y. Evaluation of methods for removing central nervous system tissue contamination from the surface of beef carcasses after splitting. J Vet Med Sci 2008; 70:1225-1230.
13. Prusiner SB. Prions. Proc Natl Acad Sci U S A 1998; 95:13363-13383. (Review). (Nobel lecture).
14. Hönig JF, Merten HA, Heinemann DE. Risk of transmission of agents associated with Creutzfeldt-Jakob disease and bovine spongiform encephalopathy. Plast Reconstr Surg 1999; 103:1324-1325.
15. Bannister SR, Powell CA. Foreign body reaction to anorganic bovine bone and autogenous bone with platelet-rich plasma in guided bone regeneration. J Periodontol 2008; 79:1116-1120.
16. Lasmézas CI, Deslys JP, Robain O, etal. Science 1997; Transmission of the BSE agent to mice in the absence of detectable abnormal prion protein. 275:402-405.
17. Baker CA, Martin D, Manuelidis L. Microglia from Creutzfeldt-Jakob disease-infected brains are infectious and show specific mRNA activation profiles. J Virol 2002; 76:10905-10913.
18. Berardi VA, Cardone F, Valanzano A, Lu M, Pocchiari M. Preparation of soluble infectious samples from scrapie-infected brain: a new tool to study the clearance of transmissible spongiform encephalopathy agents during plasma fractionation. Transfusion 2006; 46:652-658.
19. Barron RM, Campbell SL, King D, etal. High titers of transmissible spongiform encephalopathy infectivity associated with extremely low levels of PrPSc in vivo. J Biol Chem 2007; 282:35878-35886. Epub October 8, 2007.
20. Gambetti P, Dong Z, Yuan J, etal. A novel human disease with abnormal prion protein sensitive to protease. Ann Neurol 2008; 63:697-708.
21. Thackray AM, Hopkins L, Bujdoso R. Proteinase K-sensitive disease-associated ovine prion protein revealed by conformation-dependent immunoassay. Biochem J 2007; 401:475-483.
22. Tadic D, Epple M. A thorough physicochemical characterisation of 14 calcium phosphate-based bone substitution materials in comparison to natural bone. Biomaterials 2004; 25:987-994.
23. Figueiredo M, Henriques J, Martins G, Guerra F, Judas F, Figueiredo H. Physicochemical characterization of biomaterials commonly used in dentistry as bone substitutes - comparison with human bone. J Biomed Mater Res B Appl Biomater 2010; 92:409-419.
24. Giles K, Glidden DV, Beckwith R, etal. Resistance of bovine spongiform encephalopathy (BSE) prions to inactivation. PLoS Pathog 2008; 4:e1000206. Epub November 14, 2008.
25. Jeffrey M, González L. Pathology and pathogenesis of bovine spongiform encephalopathy and scrapie. Curr Top Microbiol Immunol 2004; 284:65-97. Review.
26. McLeod AH, Murdoch H, Dickinson J, etal. Proteolytic inactivation of the bovine spongiform encephalopathy agent. Biochem Biophys Res Commun 2004; 317:1165-1170. Erratum in: Biochem Biophys Res Commun 2004 Sep 3; 321(4):1069.
27. Peretz D, Supattapone S, Giles K, etal. Inactivation of prions by acidic sodium dodecyl sulfate. J Virol 2006; 80:322-331.
28. Wells GA, Hawkins SA, Green RB, etal. Preliminary observations on the pathogenesis of experimental bovine spongiform encephalopathy (BSE): an update. Vet Rec 1998; 142:103-106.
29. Wells GA, Hawkins SA, Green RB, Spencer YI, Dexter I, Dawson M. Limited detection of sternal bone marrow infectivity in the clinical phase of experimental bovine spongiform encephalopathy (BSE). Vet Rec 1999; 144:292-294.
30. Terry LA, Marsh S, Ryder SJ, Hawkins SA, Wells GA, Spencer YI. Detection of disease-specific PrP in the distal ileum of cattle exposed orally to the agent of bovine spongiform encephalopathy. Vet Rec 2003; 152:387-392.
31. Buschmann A, Groschup MH. Highly bovine spongiform encephalopathy-sensitive transgenic mice confirm the essential restriction of infectivity to the nervous system in clinically diseased cattle. J Infect Dis 2005; 192:934-942. Epub July 25, 2005.
32. Trieschmann L, Navarrete Santos A, Kaschig K, etal. Ultra-sensitive detection of prion protein fibrils by flow cytometry in blood from cattle affected with bovine spongiform encephalopathy. BMC Biotechnol 2005; 5:26.
33. Iwata N, Sato Y, Higuchi Y, etal. Distribution of PrP(Sc) in cattle with bovine spongiform encephalopathy slaughtered at abattoirs in Japan. Jpn J Infect Dis 2006; 59:100-107.
34. Arnold ME, Ryan JB, Konold T, etal. Estimating the temporal relationship between PrPSc detection and incubation period in experimental bovine spongiform encephalopathy of cattle. J Gen Virol 2007; 88:3198-3208.
35. Masujin K, Matthews D, Wells GA, Mohri S, Yokoyama T. Prions in the peripheral nerves of bovine spongiform encephalopathy-affected cattle. J Gen Virol 2007; 88:(Pt 6):1850-1858.
36. Espinosa JC, Morales M, Castilla J, Rogers M, Torres JM. Progression of prion infectivity in asymptomatic cattle after oral bovine spongiform encephalopathy challenge. J Gen Virol 2007; 88:1379-1383.
37. Kimura K, Haritani M. Distribution of accumulated prion protein in a cow with bovine spongiform encephalopathy. Vet Rec 2008; 162:822-825.
38. Murayama Y, Yoshioka M, Masujin K, etal. Sulfated dextrans enhance in vitro amplification of bovine spongiform encephalopathy PrP(Sc) and enable ultrasensitive detection of bovine PrP(Sc). PLoS ONE 2010; 5:pii: e13152.
39. Yokoyama T, Okada H, Murayama Y, Masujin K, Iwamaru Y, Mohri S. Examination of the offspring of a Japanese cow affected with L-type bovine spongiform encephalopathy. J Vet Med Sci 2011; 73:121-123. Epub August 25, 2010.
40. Balkema-Buschmann A, Eiden M, Hoffmann C, etal. BSE infectivity in the absence of detectable PrPSc accumulation in the tongue and nasal mucosa of terminally diseased cattle. J Gen Virol 2011; 92:467-476. Epub October 13, 2010.
41. Saá P, Castilla J, Soto C. Presymptomatic detection of prions in blood. Science 2006; 313:92-94.
42. Safar JG, Scott M, Monaghan J, etal. Measuring prions causing bovine spongiform encephalopathy or chronic wasting disease by immunoassays and transgenic mice. Nat Biotechnol 2002; 20:1147-1150. Epub October 21, 2002.
43. Soto C, Anderes L, Suardi S, etal. Pre-symptomatic detection of prions by cyclic amplification of protein misfolding. FEBS Lett 2005; 579:638-642.
44. http://web.archive.org/web/20100920073311/http://www.oie.int/eng/normes/mmanual/2008/pdf/2.04.06_BSE.pdf (accessed January 14, 2011).
45. Safar JG, Geschwind MD, Deering C, etal. Diagnosis of human prion disease. Proc Natl Acad Sci U S A 2005; 102:3501-3506.
46. Head MW, Knight R, Zeidler M, Yull H, Barlow A, Ironside JW. A case of protease sensitive prionopathy in a patient in the UK. Neuropathol Appl Neurobiol 2009; 35:628-632. Epub August 7, 2009.
47. Schwartz Z, Weesner T, van Dijk S, etal. Ability of deproteinized cancellous bovine bone to induce new bone formation. J Periodontol 2000; 71:1258-1269.
48. Murugan R, Panduranga Rao K, Sampath kumar TS. Heat-deproteinated xenogeneic bone from slaughterhouse waste: physico-chemical properties. Bull Mater Sci 2003; 26:523-528.
49. Wenz B, Oesch B, Horst M. Analysis of the risk of transmitting bovine spongiform encephalopathy through bone grafts derived from bovine bone. Biomaterials 2001; 22:1599-1606.
50. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193:265-275.
51. Simonian MH, Smith JA. Spectrophotometric and colorimetric determination of protein concentration. Curr Protoc Mol Biol 2006; Chapter 10:Unit 10.1A. Review.
52. Anastassiades T, Puzic O, Puzic R. Effect of solubilized bone matrix components on cultured fibroblasts derived from neonatal rat tissues. Calcif Tissue Res 1978; 26:173-179.
53. Brown P. BSE and transmission through blood. Lancet 2000; 356:955-956.
54. Brown P, Rau EH, Lemieux P, Johnson BK, Bacote AE, Gajdusek DC. Infectivity studies of both ash and air emissions from simulated incineration of scrapie-contaminated tissues. Environ Sci Technol 2004; 38:6155-6160.